StratDeck

Two stocks in Drug Manufacturers - General

Gilead Sciences vs Merck & Co.: profit, growth, debt and price compared

Merck & Co. is stronger on 4 of 7 figures: profit margin, debt, price for its expected profit and dividend. Gilead Sciences is stronger on 2: sales growth and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Gilead Sciences' storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Gilead Sciences and Merck & Co. side by side
Gilead SciencesGILDMerck & Co.MRK
Net margin−12.5%Stronger: 3.6%
Revenue growth, past yearStronger: +6.83%+4.68%
Debt to equity202.5%Stronger: 119.9%
Forward P/E16.6×Stronger: 15.4×
Dividend yield1.92%Stronger: 2.47%
AnalystsBuy · 26Buy · 26
From its 200-day averageStronger: +19.3%+6.4%

Share price over the past year

  • Gilead Sciences+32.9%
  • Merck & Co.+42.9%

18 Nov 202518 Nov 2026

Gilead Sciences or Merck & Co.: which is stronger?

  • MRK

    Which is more profitable?

    Merck & Co. keeps more of each sale as profit: 3.6% against −12.5%.

  • GILD

    Which is growing its sales faster?

    Gilead Sciences is growing its sales faster: +6.83% over the past year, against +4.68%.

  • MRK

    Which has borrowed less?

    Merck & Co. has borrowed less: its debt is 119.9% of what its shareholders own, against 202.5% for Gilead Sciences.

  • MRK

    Which costs less for the profit it is expected to make?

    Merck & Co. costs less for the profit it is expected to make: 15.4× its forward earnings, against 16.6×.

  • MRK

    Which pays more in dividends?

    Merck & Co. pays more back in dividends for what a share costs: 2.47% a year, against 1.92%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • GILD

    Which is in the stronger price trend?

    Gilead Sciences' price is in the stronger trend: 19.3% above its 200-day average, against 6.4% above.

What each company does

GILDGilead Sciences

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Reports results on 9 February 2027

MRKMerck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide.

Reports results on 2 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.